HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Ito Selected Research

Em18 antigen

8/2011Immunochromatographic test with recombinant Em18 antigen for the follow-up study of alveolar echinococcosis.
8/2006[A case of liver cysts with Em18-WB was useful for differential diagnosis].
4/2005Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis.
7/2003Evaluation of use of recombinant Em18 and affinity-purified Em18 for serological differentiation of alveolar echinococcosis from cystic echinococcosis and other parasitic infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akira Ito Research Topics

Disease

35Neoplasms (Cancer)
10/2023 - 02/2002
21Hyperthermia
09/2023 - 02/2002
18Cysticercosis
11/2019 - 06/2003
17Echinococcosis (Hydatid Cysts)
02/2016 - 02/2003
16Alveolar echinococcosis
01/2014 - 08/2002
15Melanoma (Melanoma, Malignant)
06/2023 - 03/2003
14Infections
11/2019 - 10/2002
12Neurocysticercosis
09/2015 - 06/2003
11Taeniasis
11/2019 - 02/2004
10Neoplasm Metastasis (Metastasis)
03/2023 - 01/2003
10Schizophrenia (Dementia Praecox)
02/2015 - 10/2007
9Cysts
02/2016 - 01/2006
8Osteoarthritis
12/2021 - 08/2008
7Inflammation (Inflammations)
06/2023 - 05/2003
7Myocardial Infarction
01/2023 - 10/2004
6Carcinoma (Carcinomatosis)
11/2019 - 01/2004
6Experimental Melanoma
06/2013 - 12/2003
6Acne Vulgaris
06/2013 - 12/2007
5Stroke (Strokes)
01/2023 - 04/2011
5Hepatocellular Carcinoma (Hepatoma)
06/2021 - 01/2003
5Epilepsy (Aura)
04/2020 - 11/2003
5Parasitic Diseases (Parasitic Disease)
02/2013 - 01/2005
5Toxocariasis
11/2011 - 03/2004
4Heart Failure
01/2023 - 01/2015
4Crush Injuries
12/2022 - 01/2020
4Wounds and Injuries (Trauma)
01/2018 - 01/2003
4Hyperplasia
10/2015 - 12/2003
4Communicable Diseases (Infectious Diseases)
04/2014 - 10/2002
4Alzheimer Disease (Alzheimer's Disease)
09/2008 - 12/2004
4Fibrosarcoma
02/2008 - 02/2002
4Myocardial Ischemia (Ischemic Heart Diseases)
03/2007 - 09/2004
3Body Weight (Weight, Body)
09/2023 - 01/2017
3Thrombosis (Thrombus)
01/2023 - 07/2010
3Hypoxia (Hypoxemia)
10/2021 - 01/2015
3Seizures (Absence Seizure)
08/2021 - 11/2012
3Acute Kidney Injury (Acute Renal Failure)
01/2021 - 11/2013
3Stomach Neoplasms (Stomach Cancer)
12/2020 - 01/2007
3Hypertrophy
03/2016 - 03/2011
3Rheumatoid Arthritis
01/2016 - 06/2008
3Edema (Dropsy)
01/2015 - 08/2004
3Diabetes Mellitus
04/2011 - 08/2002
3Type 2 Diabetes Mellitus (MODY)
06/2009 - 08/2002
3Prostatic Neoplasms (Prostate Cancer)
05/2008 - 09/2005
2Colonic Neoplasms (Colon Cancer)
09/2023 - 10/2022

Drug/Important Bio-Agent (IBA)

32AntigensIBA
03/2023 - 08/2002
16Proteins (Proteins, Gene)FDA Link
12/2022 - 08/2002
13EnzymesIBA
03/2023 - 08/2002
12DNA (Deoxyribonucleic Acid)IBA
11/2017 - 06/2003
12Ferrosoferric Oxide (Magnetite)FDA Link
08/2014 - 02/2002
11Mitochondrial DNA (mtDNA)IBA
04/2014 - 08/2004
11ImmunosorbentsIBA
11/2013 - 08/2002
10Liposomes (Liposome)IBA
03/2009 - 01/2003
9AntibodiesIBA
11/2019 - 11/2003
9Immunoglobulin G (IgG)IBA
11/2019 - 12/2003
8Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2010 - 02/2003
7Messenger RNA (mRNA)IBA
01/2020 - 05/2011
7nobiletinIBA
06/2013 - 02/2002
6CytokinesIBA
06/2023 - 05/2003
6Therapeutic UsesIBA
01/2019 - 07/2005
6Matrix Metalloproteinases (MMPs)IBA
09/2012 - 02/2002
5Monophenol Monooxygenase (Tyrosinase)IBA
03/2023 - 03/2007
5N-propionyl-4-S-cysteaminylphenolIBA
03/2023 - 09/2010
5Electron Transport Complex IV (Cytochrome c Oxidase)IBA
04/2016 - 01/2009
5Metalloproteases (Metalloproteinases)IBA
01/2012 - 02/2002
5Glycoproteins (Glycoprotein)IBA
01/2012 - 01/2006
4SulfurIBA
03/2023 - 03/2007
4Free RadicalsIBA
06/2022 - 01/2009
4FlavonoidsIBA
06/2013 - 02/2002
4Peptides (Polypeptides)IBA
01/2013 - 09/2008
4Praziquantel (Biltricide)FDA Link
11/2012 - 01/2006
4Insulin (Novolin)FDA Link
09/2012 - 09/2002
4ProstaglandinsIBA
09/2012 - 01/2003
4Cysteine (L-Cysteine)FDA Link
09/2012 - 08/2007
4Albendazole (Albenza)FDA Link
10/2011 - 04/2005
4Em18 antigenIBA
08/2011 - 07/2003
4Peptide Hydrolases (Proteases)FDA Link
03/2011 - 05/2005
3Biomarkers (Surrogate Marker)IBA
10/2023 - 07/2013
3TolvaptanFDA Link
01/2023 - 01/2015
3salicylhydroxamic acid (SHAM)IBA
01/2022 - 07/2014
3Transcription Factors (Transcription Factor)IBA
06/2021 - 12/2017
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 03/2010
3CreatinineIBA
01/2021 - 08/2002
3VaccinesIBA
02/2013 - 07/2005
3Tyrosine (L-Tyrosine)FDA Link
01/2013 - 03/2007
3progelatinaseIBA
12/2010 - 02/2002
3Lurasidone HydrochlorideFDA Link
07/2010 - 10/2007
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
03/2008 - 10/2004
3Lipoproteins (Lipoprotein)IBA
12/2007 - 01/2006
3HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2004 - 02/2003

Therapy/Procedure

45Therapeutics
06/2023 - 02/2002
11Immunotherapy
06/2023 - 03/2003
11Drug Therapy (Chemotherapy)
11/2022 - 04/2005
7Induced Hyperthermia (Thermotherapy)
06/2023 - 02/2003
5Stents
01/2023 - 06/2009
4Oral Administration
09/2023 - 09/2010
4Percutaneous Coronary Intervention
01/2023 - 02/2006
4Injections
10/2022 - 07/2012
4Ligation
10/2015 - 03/2014
3Transplantation
03/2022 - 09/2003
3Artificial Liver (Bioartificial Liver)
06/2021 - 12/2017